Fundraising Fox

Akadeum Life Sciences

Ann Arbor, US · Founded 2014 · Delaware corporation · 13 known investors

akadeum.com

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devicesin /akadeum-life-sciences-inc-@akadeum

Founders & leadership

JS
Jeffrey S. WilliamsDirector
BM
Brandon McNaughtonExecutive Officer, Director
JM
James MilitelloExecutive Officer
KH
Kalyan HandiqueExecutive Officer, Director
DN
Douglas NealDirector
JY
John YoungerExecutive Officer, Director
PD
Paul D'AmatoDirector
DK
Dan KidleDirector
JL
Jenni LiDirector

Investors · 13

Reported raises · per SEC filings

Form D private placements
$2.1MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalyan HandiqueExecutive Officer, Director
  • Paul D'AmatoDirector
  • Jenni LiDirector
  • James MilitelloExecutive Officer
Offering amount
$3.4M
Amount sold
$2.1M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.6MraisedApr 2025 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey S. WilliamsDirector
  • Paul D'AmatoDirector
  • Dan KidleDirector
  • Brandon McNaughtonExecutive Officer, Director
  • James MilitelloExecutive Officer
Offering amount
$7.2M
Amount sold
$5.6M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HyunDirector
  • Brandon McNaughtonExecutive Officer, Director
  • Dan KidleDirector
  • George DunbarDirector
  • John GavenonisDirector
Offering amount
$6.5M
Amount sold
$6M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$900KraisedNov 2018 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • John YoungerExecutive Officer, Director
  • Brock SiegelDirector
  • Douglas NealDirector
Offering amount
$2M
Amount sold
$900K
Minimum investment
$25K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedAug 2017 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BrownDirector
  • John YoungerExecutive Officer, Director
  • Brandon McNaughtonExecutive Officer, Director
  • William WoodDirector
  • Douglas NealDirector
Offering amount
$1.6M
Amount sold
$1.5M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$360KraisedDec 2016 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John YoungerExecutive Officer, Director
  • Douglas NealDirector
  • Brandon McNaughtonExecutive Officer, Director
Offering amount
$1M
Amount sold
$360K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$905.1KraisedAug 2015 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • Douglas NealDirector
  • John YoungerExecutive Officer, Director
Offering amount
$1M
Amount sold
$905.1K
First sale
May 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news